These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31002112)

  • 21. SET and MYND domain-containing protein 3 is overexpressed in human glioma and contributes to tumorigenicity.
    Dai B; Wan W; Zhang P; Zhang Y; Pan C; Meng G; Xiao X; Wu Z; Jia W; Zhang J; Zhang L
    Oncol Rep; 2015 Nov; 34(5):2722-30. PubMed ID: 26328527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway.
    Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S
    Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression.
    Liu YB; Mei Y; Long J; Zhang Y; Hu DL; Zhou HH
    J Exp Clin Cancer Res; 2018 Aug; 37(1):182. PubMed ID: 30075819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DPY30 is required for the enhanced proliferation, motility and epithelial-mesenchymal transition of epithelial ovarian cancer cells.
    Zhang L; Zhang S; Li A; Zhang A; Zhang S; Chen L
    Int J Mol Med; 2018 Dec; 42(6):3065-3072. PubMed ID: 30221689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ube2v1-mediated ubiquitination and degradation of Sirt1 promotes metastasis of colorectal cancer by epigenetically suppressing autophagy.
    Shen T; Cai LD; Liu YH; Li S; Gan WJ; Li XM; Wang JR; Guo PD; Zhou Q; Lu XX; Sun LN; Li JM
    J Hematol Oncol; 2018 Jul; 11(1):95. PubMed ID: 30016968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HOXB4 promotes the malignant progression of ovarian cancer via DHDDS.
    Li N; Gou JH; Xiong J; You JJ; Li ZY
    BMC Cancer; 2020 Mar; 20(1):222. PubMed ID: 32178630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KDM6B promotes ovarian cancer cell migration and invasion by induced transforming growth factor-β1 expression.
    Liang S; Yao Q; Wei D; Liu M; Geng F; Wang Q; Wang YS
    J Cell Biochem; 2019 Jan; 120(1):493-506. PubMed ID: 30277596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. β-hCG promotes epithelial ovarian cancer metastasis through ERK/MMP2 signaling pathway.
    Wu W; Gao H; Li X; Peng S; Yu J; Liu N; Zhan G; Zhu Y; Wang K; Guo X
    Cell Cycle; 2019 Jan; 18(1):46-59. PubMed ID: 30582718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SMYD3 promotes the epithelial-mesenchymal transition in breast cancer.
    Fenizia C; Bottino C; Corbetta S; Fittipaldi R; Floris P; Gaudenzi G; Carra S; Cotelli F; Vitale G; Caretti G
    Nucleic Acids Res; 2019 Feb; 47(3):1278-1293. PubMed ID: 30544196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of metformin-mediated girdin expression in metastasis of epithelial ovarian cancer.
    Dang J; Gao J; Ma F; Luo Y; Wang J; Wang D; Li W; Sun H; Li L; Liu X; Hu D; Jin Z
    Cell Biol Int; 2021 May; 45(5):1030-1037. PubMed ID: 33404163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in epithelial ovarian cancer.
    Cao Y; Shi H; Ren F; Jia Y; Zhang R
    Exp Cell Res; 2017 Oct; 359(1):185-194. PubMed ID: 28754469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression.
    Barger CJ; Zhang W; Hillman J; Stablewski AB; Higgins MJ; Vanderhyden BC; Odunsi K; Karpf AR
    Oncotarget; 2015 Sep; 6(29):27613-27. PubMed ID: 26243836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-125b Suppresses Ovarian Cancer Progression via Suppression of the Epithelial-Mesenchymal Transition Pathway by Targeting the SET Protein.
    Ying X; Wei K; Lin Z; Cui Y; Ding J; Chen Y; Xu B
    Cell Physiol Biochem; 2016; 39(2):501-10. PubMed ID: 27383536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S; Liu S; Feng J; Gao J; Xue F
    Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway.
    Li H; Zhang W; Niu C; Lin C; Wu X; Jian Y; Li Y; Ye L; Dai Y; Ouyang Y; Chen J; Qiu J; Song L; Zhang Y
    Int J Cancer; 2019 Oct; 145(7):1921-1934. PubMed ID: 30895619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of CHIP promotes ovarian cancer metastasis by inducing Snail-mediated epithelial-mesenchymal transition.
    Park SM; Park SH; Ryu KJ; Kim IK; Han H; Kim HJ; Kim SH; Hong KS; Kim H; Kim M; Cho BI; Heo JD; Kim NH; Hwang EM; Park JY; Yook JI; Cho HJ; Hwangbo C; Kim KD; Song H; Yoo J
    Mol Oncol; 2019 May; 13(5):1280-1295. PubMed ID: 30927556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
    Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
    Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome.
    Leng R; Liao G; Wang H; Kuang J; Tang L
    Med Oncol; 2015 Feb; 32(2):329. PubMed ID: 25585684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma.
    Zhou Z; Jiang H; Tu K; Yu W; Zhang J; Hu Z; Zhang H; Hao D; Huang P; Wang J; Wang A; Xiao Z; He C
    J Exp Clin Cancer Res; 2019 Jan; 38(1):18. PubMed ID: 30646949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histone methyltransferase SMYD3 promotes MRTF-A-mediated transactivation of MYL9 and migration of MCF-7 breast cancer cells.
    Luo XG; Zhang CL; Zhao WW; Liu ZP; Liu L; Mu A; Guo S; Wang N; Zhou H; Zhang TC
    Cancer Lett; 2014 Mar; 344(1):129-137. PubMed ID: 24189459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.